Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ACADIA HEALTHCARE COMPANY, INC.

(ACHC)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Acadia Healthcare : UBS Starts Acadia Healthcare at Buy With $81 Price Target

09/24/2021 | 07:46am EDT


© MT Newswires 2021
All news about ACADIA HEALTHCARE COMPANY, INC.
10/11ACADIA HEALTHCARE : Names New Chief Development Officer
MT
10/11ACADIA HEALTHCARE : Names Osei Mevs as Vice President of Government Relations
BU
10/11ACADIA HEALTHCARE : Names David Keys as Chief Development Officer
BU
10/11Acadia Healthcare Names David Keys as Chief Development Officer
CI
10/11ACADIA HEALTHCARE : Announces Date for Third Quarter 2021 Earnings Release
BU
10/05Health Care Stocks Gain in Tuesday Markets Recovery
MT
10/05Health Care Stocks Recovering in Afternoon Trading
MT
10/05ACADIA HEALTHCARE : Chief Executive Debbie Osteen to Retire; Shares Down in Early Trading
MT
10/05ACADIA HEALTHCARE : Announces Retirement of Chief Executive Officer (Form 8-K)
PU
10/05ACADIA HEALTHCARE COMPANY, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
More news
Analyst Recommendations on ACADIA HEALTHCARE COMPANY, INC.
More recommendations
Financials (USD)
Sales 2021 2 311 M - -
Net income 2021 177 M - -
Net Debt 2021 1 280 M - -
P/E ratio 2021 29,1x
Yield 2021 -
Capitalization 5 101 M 5 101 M -
EV / Sales 2021 2,76x
EV / Sales 2022 2,55x
Nbr of Employees 35 400
Free-Float 98,7%
Chart ACADIA HEALTHCARE COMPANY, INC.
Duration : Period :
Acadia Healthcare Company, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ACADIA HEALTHCARE COMPANY, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 16
Last Close Price 56,76 $
Average target price 75,14 $
Spread / Average Target 32,4%
EPS Revisions
Managers and Directors
Debra Kay Osteen Chief Executive Officer & Director
David M. Duckworth Chief Financial Officer
Reeve Byron Waud Chairman
Michael V. Genovese Chief Medical Officer
John S. Hollinsworth Executive Vice President-Operations